Mi-RNA and COVID-19

Launched by FONDAZIONE POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI IRCCS · Mar 15, 2025

Keywords

ClinConnect Summary

This clinical trial, called "Mi-RNA and COVID-19," is focused on understanding how certain molecules in our bodies, known as microRNAs (miRNAs), are connected to COVID-19 infections. Researchers want to learn how these miRNAs might relate to the severity of the illness and the risk of dying from it. COVID-19 can cause a range of problems, from mild symptoms to severe respiratory issues that may require hospitalization. By studying these miRNAs, the trial hopes to find better ways to predict and treat COVID-19.

To join this study, participants need to be at least 18 years old and must have a confirmed diagnosis of a COVID-19 infection through a specific test. However, pregnant women are not eligible to participate. If you decide to take part, you can expect to provide samples for testing and contribute to important research that could help improve care for others with COVID-19. This trial is currently recruiting participants, so it’s a chance to make a difference in the fight against this disease.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 18 years
• • diagnosis of SARS-CoV-2 infection confirmed by molecular testing on nasopharyngeal swabs
• Exclusion Criteria:
• • pregnant women